Olga Santaeularia Lozano

Title: Olga Santaeularia Lozano: Innovator in Therapeutic Solutions

Introduction

Olga Santaeularia Lozano is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of therapeutic solutions, particularly in the development of human albumin solutions. With a total of 2 patents, her work is recognized for its innovative approach to enhancing the stability and efficacy of medical treatments.

Latest Patents

Olga's latest patents focus on therapeutic human albumin solutions with low prekallikrein activator (PKA) activity. The first patent discloses a purified albumin solution of human origin characterized by its low PKA activity and stability over time. This solution has an antithrombin content equal to or greater than 0.03 mg/g of albumin. The process for obtaining this solution involves the partial extraction of antithrombin during the fractionation of human plasma. This innovative approach aims to improve the safety and effectiveness of therapeutic applications.

Career Highlights

Olga is currently associated with Grifols, S.A., a leading global healthcare company specializing in plasma-derived medicines. Her work at Grifols has allowed her to contribute to advancements in medical therapies that benefit patients worldwide.

Collaborations

Throughout her career, Olga has collaborated with notable colleagues, including Juan Ignacio Jorquera Nieto and Nuria Hosta Mateu. These collaborations have fostered a dynamic environment for innovation and research in the field of therapeutic solutions.

Conclusion

Olga Santaeularia Lozano stands out as a key figure in the development of therapeutic human albumin solutions. Her innovative patents and contributions to Grifols highlight her commitment to advancing medical science. Her work continues to impact the healthcare industry positively.